Scopus BioPharma Inc.
SCPS · OTC
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $2,146 | $1,853 | $2,067 | $5,105 |
| - Cash | $362 | $1,401 | $125 | $311 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1,784 | $451 | $1,943 | $4,794 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2,929 | -$2,679 | -$1,836 | -$1,898 |
| % Margin | – | – | – | – |
| Net Income | -$2,617 | -$2,450 | -$1,731 | -$1,899 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.066 | -0.081 | -0.082 | -0.09 |
| % Growth | 18.5% | 1.7% | 8.8% | – |
| Operating Cash Flow | -$1,009 | -$760 | -$422 | -$852 |
| Capital Expenditures | $0 | $0 | -$1,550 | $0 |
| Free Cash Flow | -$1,009 | -$760 | -$1,972 | -$852 |